Vorbereitung klinischer Studie: Safety and tolerability of an immunotherapy with a house dust mite sublingual Tablet in 2- 5-year old children sensitized to house dust mite with recurrent wheeze (SaMT)
Schlussbericht zum Verwendungsnachweis für das Vorhaben
| dc.date.accessioned | 2026-02-19T12:10:14Z | |
| dc.date.available | 2026-02-19T12:10:14Z | |
| dc.date.issued | 2025-03-21 | |
| dc.description.abstract | [no abstract available] | ger |
| dc.description.version | publishedVersion | |
| dc.identifier.uri | https://oa.tib.eu/renate/handle/123456789/30921 | |
| dc.identifier.uri | https://doi.org/10.34657/29990 | |
| dc.language.iso | ger | |
| dc.publisher | Hannover : Technische Informationsbibliothek | |
| dc.relation.affiliation | Medizinische Hochschule Hannover | |
| dc.rights.license | Creative Commons Attribution-NonDerivs 3.0 Germany | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nd/3.0/de/ | |
| dc.subject.ddc | 000 | Informatik, Information und Wissen, allgemeine Werke | |
| dc.title | Vorbereitung klinischer Studie: Safety and tolerability of an immunotherapy with a house dust mite sublingual Tablet in 2- 5-year old children sensitized to house dust mite with recurrent wheeze (SaMT) | ger |
| dc.title.subtitle | Schlussbericht zum Verwendungsnachweis für das Vorhaben | |
| dc.type | Report | |
| dcterms.extent | 3 Seiten | |
| dtf.duration | von 01.04.2022 bis 31.12.2023 | |
| dtf.funding.funder | BMFTR | |
| dtf.funding.program | 82DZLD62B1 | |
| tib.accessRights | openAccess |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- BMBF82DZLD62B1.pdf
- Size:
- 130.67 KB
- Format:
- Adobe Portable Document Format
- Description:
